Vaxart (VXRT) announced the initiation of a Phase 1, open label, dose ranging clinical trial evaluating its second-generation oral norovirus ...

The Phase 1 trial is an open label, dose ranging clinical study designed to evaluate Vaxart’s second-generation oral norovirus vaccine constructs head-to-head against its first-generation constructs.

Ranked by Number of employees in Georgia dedicated to FinTech Ranked by 2024 Revenue from IT Consulting Ranked by Austin employees 2025-Q1 Showcase your company news with guaranteed exposure both ...